|Bid||163.88 x 1300|
|Ask||166.92 x 1200|
|Day's Range||165.40 - 166.13|
|52 Week Range||133.55 - 170.86|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||0.94|
|Expense Ratio (net)||0.20%|
The chart below shows Allergan’s (AGN) revenues and earnings per share (or EPS) since 1Q17. For 1Q18, Allergan reported EPS of $3.74 on revenues of ~$3.7 billion, representing 2.8% growth in revenues compared to revenues of ~$3.6 billion during 1Q17.
Johnson & Johnson (JNJ) reported 12.6% growth in its revenues to $20.0 billion during 1Q18 as compared to revenues of $17.8 billion during 1Q17. The company surpassed Wall Street analyst estimates for EPS (earnings per share) and revenues and reported EPS of $2.06 on revenues of $20.0 billion during 1Q18 against estimates for EPS of $2.00 on revenues of $19.4 billion during 1Q17.